title: Universal influenza vaccine: the holy grail?
abstract: Influenza vaccines have been available since the 1950s and have seen increasingly wide use as public health authorities expanded recommendations. Recent events including shortages and avian influenza outbreaks have renewed interest in influenza vaccines, particularly improved vaccines.
authors.affiliation: VaxInnate Corporation, 3 Cedar Brook Drive, Cranbury, NJ 08512, USA. alan.shaw@vaxinnate.com
authors.forename: Alan R
authors.initials: AR
authors.lastname: Shaw
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry; D000914:Antibodies, Viral / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology*; D035843:Biomedical Research / Q000639:trends; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000458:organization & administration; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000276:immunology; D006801:Humans; D009980:Influenza A virus / Q000276:immunology* / Q000472:pathogenicity; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D013678:Technology, Pharmaceutical / Q000639:trends; D014763:Viral Matrix Proteins / Q000276:immunology; D000086082:Viroporin Proteins
chemical_list: D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D000956:Antigens, Viral; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D007252:Influenza Vaccines; D014763:Viral Matrix Proteins; C488937:M2 protein, Influenza A virus; D000086082:Viroporin Proteins